DNA adducts in relation to lung tumour outcome are not markers of susceptibility following a single dose treatment of SWR, BALB/c and C57BL/6J mice with N-nitrosodiethylamine

V. Oreffo Medical Research Council, Toxicology Unit, Hodgkin Building, University of Leicester, PO Box 138, Lancaster Road, Leicester, LE1 9HN, UK

R. Singh Proctor & Gamble (HABC) Ltd, Lovett House, Lovett Road, Staines, Middlesex, TW18 3AZ, UK

K. J. Rich Medical Research Council, Toxicology Unit, Hodgkin Building, University of Leicester, PO Box 138, Lancaster Road, Leicester, LE1 9HN, UK

D. E. G. Shuker Medical Research Council, Toxicology Unit, Hodgkin Building, University of Leicester, PO Box 138, Lancaster Road, Leicester, LE1 9HN, UK

P. Carthew Toxicology Unit, Imperial College London, St Dunstan Road, London, W6 8RP, UK

R. Cordero Department of Molecular Toxicology, TNO Food and Nutrition Research Institute, PO Box 360, 3700 AJ Zeist, The Netherlands

J. H. M. Van Delft Medical Research Council, Toxicology Unit, Hodgkin Building, University of Leicester, PO Box 138, Lancaster Road, Leicester, LE1 9HN, UK

P. B. Farmer Medical Research Council, Toxicology Unit, Hodgkin Building, University of Leicester, PO Box 138, Lancaster Road, Leicester, LE1 9HN, UK

show all

DNA adducts in relation to lung tumour outcome are not markers of susceptibility following a single dose treatment of SWR, BALB/c and C57BL/6J mice with N-nitrosodiethylamine

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

DNA adducts in relation to lung tumour outcome are not markers of susceptibility following a single dose treatment of SWR, BALB/c and C57BL/6J mice with N-nitrosodiethylamine

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date